SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 274 filers reported holding SEATTLE GENETICS INC in Q4 2016. The put-call ratio across all filers is 2.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $10,948,000 | -5.3% | 54,846 | -14.1% | 0.01% | -18.2% |
Q2 2020 | $11,563,000 | +99.4% | 63,825 | +30.6% | 0.01% | +57.1% |
Q1 2020 | $5,798,000 | -31.7% | 48,854 | -34.3% | 0.01% | +16.7% |
Q4 2019 | $8,495,000 | +70.1% | 74,343 | +27.1% | 0.01% | +50.0% |
Q3 2019 | $4,994,000 | +21.5% | 58,482 | -1.5% | 0.00% | +33.3% |
Q2 2019 | $4,111,000 | -28.6% | 59,389 | -24.5% | 0.00% | -40.0% |
Q1 2019 | $5,758,000 | +36.1% | 78,616 | +5.3% | 0.01% | +25.0% |
Q4 2018 | $4,231,000 | -15.1% | 74,668 | +15.5% | 0.00% | 0.0% |
Q3 2018 | $4,984,000 | +543.1% | 64,640 | +453.3% | 0.00% | +300.0% |
Q2 2018 | $775,000 | +41.9% | 11,682 | +12.1% | 0.00% | – |
Q1 2018 | $546,000 | +21.6% | 10,417 | +24.3% | 0.00% | – |
Q4 2017 | $449,000 | +731.5% | 8,381 | +727.3% | 0.00% | – |
Q3 2017 | $54,000 | -41.3% | 1,013 | -42.7% | 0.00% | – |
Q2 2017 | $92,000 | -79.7% | 1,767 | -75.6% | 0.00% | – |
Q1 2017 | $454,000 | +266.1% | 7,235 | +280.2% | 0.00% | – |
Q4 2016 | $124,000 | +117.5% | 1,903 | +81.2% | 0.00% | – |
Q3 2016 | $57,000 | +35.7% | 1,050 | 0.0% | 0.00% | – |
Q2 2016 | $42,000 | +320.0% | 1,050 | +288.9% | 0.00% | – |
Q1 2016 | $10,000 | -67.7% | 270 | -60.8% | 0.00% | – |
Q4 2015 | $31,000 | +121.4% | 688 | +78.7% | 0.00% | – |
Q3 2015 | $14,000 | -73.6% | 385 | -65.0% | 0.00% | – |
Q2 2015 | $53,000 | +5200.0% | 1,100 | +4900.0% | 0.00% | – |
Q1 2015 | $1,000 | -96.9% | 22 | -97.8% | 0.00% | – |
Q4 2014 | $32,000 | -25.6% | 1,000 | -13.0% | 0.00% | – |
Q3 2014 | $43,000 | -10.4% | 1,149 | -8.0% | 0.00% | – |
Q2 2014 | $48,000 | +242.9% | 1,249 | +316.3% | 0.00% | – |
Q1 2014 | $14,000 | -53.3% | 300 | -60.0% | 0.00% | – |
Q4 2013 | $30,000 | -97.9% | 750 | -97.7% | 0.00% | -100.0% |
Q3 2013 | $1,414,000 | +1891.5% | 32,250 | +1333.3% | 0.00% | – |
Q2 2013 | $71,000 | – | 2,250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |